You're absolutely right, the opportunity to investigate pre-treatment is almost certainly gone
the study physician attributed the death to pre-existing coronary artery disease unrelated to the drug, but the FDA's Pharmacy Compounding Advisory Committee cited this "unresolved cardiac signal" in December 2024 as a reason to keep the compound off the approved compounding list
Our team is made up of registered nurses, nurse practitioners, and physician associates, and all of our clinics are overseen by board-certified dermatologists
This space contains blood vessels and lymphatic channels that absorb the peptide into circulation while also allowing some local tissue effects
And you know, I mean, to me, you know, the question is, was it good science
This is the most significant movement on peptides in three years, and its worth understanding precisely including the parts that dont make a good headline: What the panel did